VITRO, S.A. distributes and commercializes SIGNOSIS’s products; this Company is focused on developing innovative and unique products for life science research and the search of new applications on clinic’s diagnostic. It has been developing a new methodology that allows analyzing miRNA in a semi-quantitative way contributing to significance advantage in its study.
- Higher sensitivity and better discrimination power: Allow difference between miRNA isoforms.
- We do not need to do isolation of miRNA: It could be used the total RNA to make the assays.
- Simple and direct protocol
- Economic
- We do not need complex technologies neither complex machine.
- It could be personalized the miRNA’s study.
The most innovative products are:
For more information contact us.